SWOBY vs LLY: Which Stock is Better?

Side-by-side comparison of Swedish Orphan Biovitrum AB (publ) and Eli Lilly & Co in 2026

Comparison Updated:

SWOBY

Swedish Orphan Biovitrum AB (publ)

$19.63

LLY

Eli Lilly & Co

$903.99

Key Metrics Comparison

MetricSWOBYLLYWinner
Market Cap$14.20B$809.09BLLY
P/E Ratio280.3939.32LLY
EPS (TTM)$0.07$22.99LLY
Revenue Growth0.1%0.4%LLY
Gross Margin78.2%83.0%LLY

Analyze SWOBY

Full quant analysis

Analyze LLY

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SWOBY or LLY a better investment?

Comparing SWOBY and LLY: Swedish Orphan Biovitrum AB (publ) has a market cap of $14.20B while Eli Lilly & Co has $809.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SWOBY and LLY?

SWOBY (Swedish Orphan Biovitrum AB (publ)) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SWOBY or LLY?

Based on P/E ratios, LLY trades at a lower multiple (39.3x vs 280.4x).

Which is growing faster: SWOBY or LLY?

LLY has higher revenue growth at 0.4% vs 0.1% for SWOBY.

Which company is more profitable: SWOBY or LLY?

Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 78.2% for SWOBY.

Which is the larger company: SWOBY or LLY?

Eli Lilly & Co (LLY) is larger with a market cap of $809.09B compared to $14.20B for SWOBY.

Should I buy SWOBY or LLY in 2026?

Both SWOBY and LLY have investment merit. SWOBY trades at $19.63 while LLY trades at $903.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SWOBY and LLY stock?

Key differences: Market Cap ($14.20B vs $809.09B), P/E Ratio (280.4x vs 39.3x), Revenue Growth (0.1% vs 0.4%), Gross Margin (78.2% vs 83.0%).

Popular Stock Comparisons